Caxton Associates (New York)’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-50,000
Closed -$5.28M 480
2017
Q2
$5.28M Buy
+50,000
New +$5.44M 0.2% 130

Other funds holding ALB

Caxton Associates (New York)'s ALB Position: Q1 2024 in Review

Caxton Associates (New York) sold out of Albemarle (ALB) in Q1 2024, closing a stake of 12,881 shares — an estimated $1.86M sold.

Caxton Associates (New York) first reported a position in ALB in Q2 2013 and held it in 10 quarters. The position peaked at $9.47M in Q4 2016. 916 funds tracked by Wall St. Rank hold ALB as of Q1 2024.

  • Caxton Associates (New York) reported no remaining Albemarle position as of Q1 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 12,881 Albemarle shares in Q1 2024, an estimated $1.86M.
  • Caxton Associates (New York) first reported a position in Albemarle in Q2 2013 and held it in 10 quarters.
  • Caxton Associates (New York)'s Albemarle position peaked at $9.47M in Q4 2016.
  • 916 funds tracked by Wall St. Rank held Albemarle as of Q1 2024.

Based on Caxton Associates (New York)'s 13F filing for Q1 2024, filed 15 May 2024.